1. European Urology Oncology
Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution 
Riccardo Bertolo, Juan Garisto, Julien Dagenais, Daniel Sagalovich, Robert Stein, Khaled Fareed, Tianming Gao, Sherif Armanyous, Amr Fergany, Michael Lioudis, Jihad Kaouk 
European Urology Oncology 
DOI: /j.euo
Copyright © Terms and Conditions

2. Fig. 1
Cumulative incidence curves for (A) renal cell carcinoma mortality (1.80% at 5 and 7 yr) and other-cause mortality (6.47% at 5 yr, 9.30% at 7 yr); (B) local recurrence (3.61% at 5 yr, 4.16% at 7 yr); and (C) metastasis (3.24% at 5 yr, 4.57% at 7 yr).
European Urology Oncology DOI: ( /j.euo )
Copyright © Terms and Conditions

3. Fig. 2
Estimated glomerular filtration rate (eGFR) during follow-up. eGFR was estimated using the Chronic Kidney Disease Epidemiology Collaboration formula, after adjusting for age (continuous), gender, and race (white/non-white). * Last follow-up was at a median of 46 mo (interquartile range 30–58). CI = confidence interval.
European Urology Oncology DOI: ( /j.euo )
Copyright © Terms and Conditions

4. European Urology Oncology DOI: (10.1016/j.euo.2018.06.012)
Copyright © Terms and Conditions

5. European Urology Oncology DOI: (10.1016/j.euo.2018.06.012)
Copyright © Terms and Conditions

6. European Urology Oncology DOI: (10.1016/j.euo.2018.06.012)
Copyright © Terms and Conditions

7. European Urology Oncology DOI: (10.1016/j.euo.2018.06.012)
Copyright © Terms and Conditions